The FDA Let ZYN Say "Lower Risk". Here Is Exactly What That Covers
On 30 June 2026 the United States Food and Drug Administration granted modified risk orders to Swedish Match USA for 20 ZYN nicotine pouch products, permitting one specific sentence to appear in their American marketing. That order is the source of the "lower risk" headlines that ran on 5 August. It applies to named products, sold by one company, in one country. It has no legal force in Vietnam, and VinaPouches does not make that claim about anything we sell.
This page exists because the wire coverage merged two different regulatory actions into a single story, and because the resulting headline is easy to read as a general statement about nicotine pouches. It is not one.
Two FDA actions, three weeks apart
The coverage that circulated on 5 August described a "lower risk" authorisation. The FDA's own records show two distinct decisions.
The first, dated 30 June 2026, was a set of modified risk granted orders to Swedish Match USA for 20 ZYN products, each in two strengths, 3 milligram and 6 milligram. A modified risk order is the only mechanism by which a tobacco product may legally carry a comparative risk statement in American marketing. These same products had already been authorised for sale on 16 January 2025 through the premarket tobacco product application pathway — but at that time without any modified risk claim. The claim came separately, after a public docket opened in June 2025 and a Tobacco Products Scientific Advisory Committee meeting in January 2026.
The second, dated 4 August 2026, was a marketing authorisation to Helix Innovations LLC for four products under the on! brand: Rich Berry 2mg, Cappuccino 2mg, Cappuccino 4mg and Autumn Spice 2mg. It came through the FDA's nicotine pouch pilot programme, which was set up to speed the review process. No modified risk claim was attached to it. Those four products may be sold in the United States; they may not carry the ZYN sentence.
Headlines that placed the words "lower risk" and the August date in the same sentence were describing the June order using the August news peg.
The exact sentence the FDA authorised
The order permits one wording, and the FDA published it verbatim:
"Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis."
Three things are worth noticing about that sentence, because they are what distinguishes it from the headline version.
It is comparative, and the comparison is to cigarettes. It says nothing about the risk of using a pouch compared with using nothing.
It is conditional on replacement. The word is "instead". The FDA's own pilot-programme notice makes the same point about switching in general terms, noting that dual use — continuing to smoke while also using pouches — does not deliver the same reduction.
It is brand-specific and product-specific. It names ZYN. It covers 20 products at 3mg and 6mg. It is not a finding about the category.
What the FDA did not say
The agency has been consistent, across both notices, that an authorisation is not a safety endorsement. Products cleared this way are not "FDA approved". The FDA's standard is a population-level judgement — whether a product offers greater benefit than risk to the United States population as a whole, weighing adults who might switch against the risk to young people and non-users. That is a public health calculation about a country. It is not a statement that the product is safe, and it is not advice to any individual.
The American Lung Association's federal advocacy director responded to the August authorisation by saying that every new flavoured tobacco product authorised by the agency is "another gamble with kids' health". We include that not to adjudicate it but because a page reporting a regulatory decision should report that the decision was contested.
Why none of this transfers to Vietnam
An FDA order is an instrument of American law. It authorises specific marketing language in the American market. It does not change what a product is, and it does not travel.
Vietnam's own position is moving in a different direction. The Ministry of Health's draft amendment dated 20 July 2026 names túi ngậm nicotine explicitly and proposes a prohibition from 1 January 2027, and Resolution 11/2026/UBTVQH16 scheduled the matter for the National Assembly session in October 2026. Nothing an American regulator decided in June or August affects that timetable.
So the honest summary for a reader in Vietnam is narrow: a foreign regulator, applying a domestic legal test, permitted one company to print one comparative sentence about 20 of its products. That is the whole of it.
How it relates to what we actually sell
We stock ZYN, so it is fair to ask whether the order touches our shelves. Counted from our catalogue: we list 42 ZYN products, across six per-pouch strengths — 3, 6, 9, 12, 15 and 18mg.
The FDA order covers 3mg and 6mg. 17 of our 42 ZYN products sit at those two strengths. 24 sit at strengths the order does not cover at all. Even that overlap is a strength match rather than a product match: the order names specific American SKUs, and a can sold in Vietnam is not automatically one of them.
We do not stock on! at all, so the 4 August authorisation covers nothing on this site. We carry 49 brands; that is not one of them.
We are not going to print the ZYN sentence on our product pages, in either language. It was granted to a specific company for a specific market under a specific legal test, and reproducing it here would be borrowing a regulator's authority for a claim we have no standing to make.
What this changes for a buyer here
Practically, nothing. The strengths on a can are unchanged. Our per-pouch figures still come from what a maker publishes, and where a maker publishes only a concentration in milligrams per gram we still show no per-pouch dose rather than converting one. Nicotine is still an addictive substance and these products are still sold only to adults.
What has changed is the information environment. For the next few months, search results and social posts will carry a headline implying a regulator has declared nicotine pouches lower risk. The accurate version is longer, more boring, and worth knowing: one agency, one brand, 20 products, two strengths, one sentence, one country.
Nicotine is an addictive substance and raises heart rate and blood pressure. These products are for adults 18 and over who already use nicotine. Keep away from children and pets — a used pouch still contains nicotine.
This article reports a regulatory decision taken in the United States and is general information, not legal or medical advice. VinaPouches makes no claim about the comparative health risk of any product it sells. Regulation of oral nicotine products in Vietnam is changing and should be re-checked after the National Assembly session of October 2026. FDA actions are cited from fda.gov as published. Product figures are counted from the VinaPouches catalogue. Last reviewed: 05/08/2026.
Frequently asked questions
A nicotine pouch is a small white pouch of nicotine, plant fibre, flavouring and water that you park between your upper lip and gum for 15 to 60 minutes. No tobacco, no smoke, no vapour, no spitting. Nicotine crosses the gum lining rather than the lungs, so nothing is inhaled and nothing is burnt. A pouch leaves no smell on your hands, clothes or breath, which is why they are used at a desk, on a motorbike, in a meeting or on a flight where smoking is impossible. Pouches come in strengths from 3mg to 25mg and in slim, mini and regular formats.
Swedish snus is made from ground tobacco leaf and is brown; nicotine pouches are white and use plant fibre in place of tobacco. Both sit under the lip. Everything VinaPouches sells is the white, tobacco-free kind. The practical differences: white pouches do not stain teeth the way brown snus can, they release flavour rather than tobacco taste, and they produce far less saliva. Several brands in our catalog — Skruf, Lundgrens, Siberia — are old Swedish snus houses that now also make the white tobacco-free version. When a heritage brand appears here, it is their white line.
No. Every pouch VinaPouches sells is tobacco-free: nicotine, plant-based fibre (usually eucalyptus or pine cellulose), food-grade flavouring, sweetener and water. No tobacco leaf, dust or stem is used at any stage. Tobacco-free does not mean nicotine-free. The nicotine in a white pouch is still nicotine and is still addictive; it is simply not delivered on a bed of tobacco. If you want a product with no nicotine at all, look at the Zero and Energy lines.
VinaPouches sells only to adults aged 18 and over. Age is confirmed at the age gate on entry and again at checkout, and couriers may ask for ID on delivery. Orders that fail an age check are cancelled. Nicotine pouches are not for people who do not already use nicotine, at any age. Buying on behalf of someone under 18 is a breach of our terms and will close the account.
Oral nicotine pouches are not named in Vietnam's ban on e-cigarettes and heated tobacco (Resolution 173/2024/QH15, in force from 1 January 2025), and no Vietnamese statute currently in force names them either way. Resolution 173/2024/QH15, passed by the National Assembly on 30 November 2024, prohibits the production, trade, import, storage, transport and use of e-cigarettes and heated tobacco products from 1 January 2025. Its scope is written around those two categories. Oral nicotine pouches — pouches placed under the lip, containing no tobacco and involving no heating or aerosol — are a separate product category and are not listed. A draft amendment to the Law on Prevention and Control of Tobacco Harms, which would bring oral nicotine products including `túi ngậm nicotine` into a defined regulatory category, has been under preparation and is expected to reach a National Assembly vote around October 2026. If it passes, this answer changes. VinaPouches will update this entry and its review date within seven days of any change in the published text of the law. The Ministry of Health's draft amendment dated 20 July 2026 names túi ngậm nicotine explicitly and proposes a ban from 1 January 2027; Resolution 11/2026/UBTVQH16 scheduled it for the October 2026 National Assembly session.